![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
DW Hay, RM Muccitelli, SS Tucker, LM Vickery-Clark, KA Wilson, JG Gleason, RF Hall, MA Wasserman and TJ Torphy
Department of Pharmacology, Smith Kline & French Laboratories, King of Prussia, Pennsylvania.
In this report, we describe the in vitro and in vivo pharmacologic profile of 2(S)-hydroxy-3(R)-[(2-carboxyethyl)thio]-3-[2-(8- phenyloctyl)pheny l]- propanoic acid (SK&F 104353) in guinea pig and human airways. In the isolated guinea pig trachea, SK&F 104353 was a potent, competitive antagonist of leukotriene (LT) D4-induced contractions (pA2 = 8.6). In contrast, SK&F 104353 produced little effect on LTC4 concentration-response curves under conditions where the bioconversion of LTC4 to LTD4 was inhibited. LTE4-induced contractions in guinea pig trachea were sensitive to inhibition by SK&F 104353 (pKB greater than 8.9). SK&F 104353 (10 microM) had no intrinsic contractile activity and was without effect on contractions produced by KCl, histamine, prostaglandin D2, platelet-activating factor or U-44069 in guinea pig trachea. Furthermore, unlike other purported LT antagonists, LT 171883 and FPL 55712, SK&F 104353 (30 microM) did not inhibit cyclic nucleotide phosphodiesterase activity measured in homogenates from canine tracheal smooth muscle. In the isolated human bronchus, SK&F 104353 produced concentration-dependent rightward shifts in LTD4 concentration-response curves and, unlike in guinea pig trachea, was an effective antagonist of LTC4-induced contractions with a pKB of 8.0 to 8.4. This provides further evidence that, in contrast to guinea pig airways, responses produced by LTC4 and LTD4 in human bronchus appear to be mediated via the same LT receptor population. SK&F 104353 was also an effective antagonist of LTE4-induced responses in human bronchus (pKB greater than 8.2).(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  C. Brink, S.-E. Dahlen, J. Drazen, J. F. Evans, D. W. P. Hay, S. Nicosia, C. N. Serhan, T. Shimizu, and T. Yokomizo International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors Pharmacol. Rev., March 1, 2003; 55(1): 195 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ravasi, V. Capra, M. Mezzetti, S. Nicosia, and G. E. Rovati A Kinetic Binding Study to Evaluate the Pharmacological Profile of a Specific Leukotriene C4 Binding Site Not Coupled to Contraction in Human Lung Parenchyma Mol. Pharmacol., June 1, 2000; 57(6): 1182 - 1189. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. NICOSIA, V. CAPRA, S. RAVASI, and G. ENRICO ROVATI Binding to Cysteinyl-Leukotriene Receptors Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S46 - 50. [Full Text] [PDF]
|
|
|
|
|
|
H. M. Sarau, R. S. Ames, J. Chambers, C. Ellis, N. Elshourbagy, J. J. Foley, D. B. Schmidt, R. M. Muccitelli, O. Jenkins, P. R. Murdock, et al. ACCELERATED COMMUNICATION: Identification, Molecular Cloning, Expression, and Characterization of a Cysteinyl Leukotriene Receptor Mol. Pharmacol., September 1, 1999; 56(3): 657 - 663. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Bannenberg, S.-E. Dahlen, M. Luijerink, G. Lundqvist, and R. Morgenstern Leukotriene C4 Is a Tight-binding Inhibitor of Microsomal Glutathione Transferase-1. EFFECTS OF LEUKOTRIENE PATHWAY MODIFIERS J. Biol. Chem., January 22, 1999; 274(4): 1994 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Drazen, E. Israel, and P. M. O'Byrne Treatment of Asthma with Drugs Modifying the Leukotriene Pathway N. Engl. J. Med., January 21, 1999; 340(3): 197 - 206. [Full Text] [PDF]
|
|
|
|
|
|
J. M. DRAZEN Leukotrienes as Mediators of Airway Obstruction Am. J. Respir. Crit. Care Med., November 1, 1998; 158(2007): S193 - S200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Panettieri Jr., E. M. L. Tan, V. Ciocca, M. A. Luttmann, T. B. Leonard, and D. W. P. Hay Effects of LTD4 on Human Airway Smooth Muscle Cell Proliferation, Matrix Expression, and Contraction In Vitro: Differential Sensitivity to Cysteinyl Leukotriene Receptor Antagonists Am. J. Respir. Cell Mol. Biol., September 1, 1998; 19(3): 453 - 461. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. E. Pedersen, B. S. Bochner, and B. J. Undem Cysteinyl Leukotrienes Induce P-Selectin Expression in Human Endothelial Cells via a Non-CysLT1 Receptor-Mediated Mechanism J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 655 - 662. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
